Developing Personalised and Portable Point-Of-Care Testing (POCT) Microtechnologies for Rapid Thrombotic Risk and Anticoagulant Dosage Assessment

Start year: 2024

Summary: This project endeavors to pioneer innovative microtechnologies for the diagnosis and monitoring of blood clots for cardiovascular patients by developing a suite of microtechnologies and a portable handheld device that will provide clinicians with accurate and efficient tools to determine appropriate drug dosages. The innovative nature of this project is also expected to inspire further advancements in the biotech industry, ultimately contribute to improved patient care and outcomes.

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.